Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2727-2733
Published online before print May 23, 2005, doi: 10.1161/CIRCULATIONAHA.104.479295
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/21/2727    most recent
CIRCULATIONAHA.104.479295v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nam, G.-B.
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nam, G.-B.
Right arrow Articles by Antzelevitch, C.
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Electrocardiology
Right arrow Arrythmias-basic studies

(Circulation. 2005;111:2727-2733.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia

Gi-Byoung Nam, MD, PhD; Alexander Burashnikov, PhD; Charles Antzelevitch, PhD

From the Masonic Medical Research Laboratory, Utica, NY.

Reprint requests to Charles Antzelevitch, PhD, Gordon K. Moe Scholar, Masonic Medical Research Laboratory, 2150 Bleecker St, Utica, NY 13501-1787. E-mail ca{at}mmrl.edu

Received May 28, 2004; revision received January 20, 2005; accepted January 25, 2005.

Background— Mutations in the ryanodine 2 receptor (RyR2) gene have been identified in patients with catecholaminergic polymorphic ventricular tachycardia. We examined the cellular basis for the ECG features and arrhythmia mechanisms using low-dose caffeine to mimic the defective calcium homeostasis encountered under these conditions.

Methods and Results— A transmural ECG and action potentials were recorded simultaneously from epicardial, M, and endocardial cells in arterially perfused canine ventricular wedge preparations. Caffeine alone produced no change (10 to 100 µmol/L) or a slight abbreviation (300 µmol/L) of the QT interval and no change in transmural dispersion of repolarization. Isoproterenol (100 nmol/L) alone induced sustained monomorphic ventricular tachycardia (VT) that originated in the epicardium in 3 of 14 wedge preparations. Isoproterenol in the presence of caffeine (100 to 300 µmol/L) induced epicardial VT in 9 of 16 wedge preparations. Delayed afterdepolarization–induced triggered beats that originated in the epicardium were associated with an increased Tpeak-Tend interval and transmural dispersion of repolarization. Bidirectional VT developed in 11 of 16 wedge preparations as a consequence of alternation in the origin of ectopic activity between endocardial, M, and epicardial regions. Single extrastimuli delivered during sustained epicardial VT induced a rapid polymorphic VT/ventricular fibrillation (VF) in 3 of 9 wedges. Spontaneous polymorphic VT was observed in 3 of 16 preparations. Propranolol (1.0 µmol/L) or verapamil (1.0 µmol/L) completely suppressed ectopic activity that arose from the epicardium and prevented induction of polymorphic VT.

Conclusions— Our data suggest delayed afterdepolarization–induced extrasystolic activity serves to trigger catecholamine-induced VT/VF under conditions of defective calcium handling. Epicardial origin of the ectopic beats increases transmural dispersion of repolarization, thus providing the substrate for the development of reentrant tachyarrhythmias that underlie rapid polymorphic VT/VF.


Key Words: antiarrhythmia agents • arrhythmia • catecholamines • electrocardiography • tachyarrhythmias




This article has been cited by other articles:


Home page
EuropaceHome page
B. Berte, B. Eyskens, G. Meyfroidt, and R. Willems
Bidirectional ventricular tachycardia in fulminant myocarditis
Europace, May 1, 2008; (2008) eun105v1.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Liu and S. G. Priori
Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin
Cardiovasc Res, January 15, 2008; 77(2): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. H. George
Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
Cardiovasc Res, January 15, 2008; 77(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Gyorke and D. Terentyev
Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease
Cardiovasc Res, January 15, 2008; 77(2): 245 - 255.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Cerrone, S. F. Noujaim, E. G. Tolkacheva, A. Talkachou, R. O'Connell, O. Berenfeld, J. Anumonwo, S. V. Pandit, K. Vikstrom, C. Napolitano, et al.
Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
Circ. Res., November 9, 2007; 101(10): 1039 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Antzelevitch
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Paavola, M. Viitasalo, P. J. Laitinen-Forsblom, M. Pasternack, H. Swan, I. Tikkanen, L. Toivonen, K. Kontula, and M. Laine
Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves
Eur. Heart J., May 1, 2007; 28(9): 1135 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. P. Katra, T. Oya, G. S. Hoeker, and K. R. Laurita
Ryanodine receptor dysfunction and triggered activity in the heart
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2144 - H2151.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. Yuan, G.-C. Fan, M. Dong, B. Altschafl, A. Diwan, X. Ren, H. H. Hahn, W. Zhao, J. R. Waggoner, L. R. Jones, et al.
Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity
Circulation, January 23, 2007; 115(3): 300 - 309.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D.A. Eisner, L.A. Venetucci, and A.W. Trafford
Life, sudden death, and intracellular calcium.
Circ. Res., August 4, 2006; 99(3): 223 - 224.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. Terentyev, A. Nori, M. Santoro, S. Viatchenko-Karpinski, Z. Kubalova, I. Gyorke, R. Terentyeva, S. Vedamoorthyrao, N. A. Blom, G. Valle, et al.
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death
Circ. Res., May 12, 2006; 98(9): 1151 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. H. George, H. Jundi, N. Walters, N. L. Thomas, R. R. West, and F. A. Lai
Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction
Circ. Res., January 6, 2006; 98(1): 88 - 97.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Roberts
Genomics and Cardiac Arrhythmias
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 9 - 21.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Viskin and C. Antzelevitch
The Cardiologists' Worst Nightmare: Sudden Death From "Benign" Ventricular Arrhythmias
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1295 - 1297.
[Full Text] [PDF]